Abstract:OBJECTIVE:To investigate if CpG-oligodeoxynucleotides (CpG-ODN) intervention has inhibitory effects on the development of airway remodeling in an ovalbumin (OVA)-sensitized mouse model of chronic asthma.METHODS:Forty female C57BL/6 mice were randomly divided into four groups (n = 10): (1) Group A (chronic asthma model): mice were sensitized by intraperitoneal injection of OVA (10 microg) precipitated with aluminium hydroxide (100 microg) on days 1 and 14. From day 21, the mice were challenged by nebulized 2.5% OVA solution (30 min/d, three times a week for 8 weeks). (2) Group B (CpG-ODN intervention group): mice were sensitized and challenged as above, and were given 60 microg CpG-ODN by intraperitoneal injection for once every two weeks. (3) Group C (GpG-ODN control): Mice were given GpC-ODN instead of CpG motifs, other treatments same as Group B. (4) Group D (saline control): mice were sensitized and challenged by saline. All mice were killed 24 h after the final OVA challenge. Blood was obtained for eosinophil counts and measurement of serum IgE by enzyme-linked immunoabsorbent assay (ELISA). Bronchoalveolar lavage fluid (BALF) was collected for total and differential counts. The concentration of interleukin-13 (IL-13) and transforming growth factor-beta1 (TGF-beta(1)) in BALF was measured by ELISA. The left lung was isolated for pathological examination. Lung sections were stained with hematoxylin and eosin (HE), and Masson's trichrome. Other sections were prepared for immunohistochemistry using monoclonal antibodies against alpha-smooth muscle actin (alpha-SMA) and TGF-beta(1).RESULTS:The eosinophil count [(89 +/- 10) x 10(4)/ml], serum IgE [(279 +/- 53) ng/ml], BALF eosinophils [(6.30 +/- 1.30) x 10(5)/ml] and the concentrations of BALF IL-13 [(4 015 +/- 361) pg/ml] and TGF-beta(1) [(356 +/- 64) pg/ml] in the OVA-sensitized mice (Group A) showed significant difference as compared with those in the NS control group (Group D, t values are 24.0, 15.7, 14.7, 18.4, 12.0 and 18.9 respectively, all P < 0.01). In Group A, the percentages of positive staining area in Masson's trichrome, alpha-SMA staining and TGF-beta(1) staining were (29.7 +/- 4.2)%, (45 +/- 7)% and (34 +/- 4)% respectively. These percentages were significantly different from those in the NS control group (Group D, t values are 18.0, 15.6 and 17.9 respectively, all P < 0.01). In mice treated with CpG-ODN (Group B), the percentages of positive staining area in Masson's trichrome, alpha-SMA staining and TGF-beta(1) staining were (13.8 +/- 3.2)%, (24.7 +/- 3.1)%, (18 +/- 4)% respectively, which were significantly different from those in Group A (t values are 9.5, 8.9 and 9.8 respectively, all P < 0.05).CONCLUSIONS:This study demonstrated that CpG-ODN could prevent Th2 responses, eosinophilic inflammation and the development of airway remodeling. Its inhibitory effect on airway remodeling might, in part, be due to inhibition of the expression of cytokines such as TGF-beta(1) and IL-13.

Mechanisms of CpG-ODNs inhibiting the airway remodeling of chronic asthma in mice

[The Effects of CpG-oligodeoxynucleotides on Airway Remodeling in Chronic Asthmatic Mice].

Carbocistein improves airway remodeling in asthmatic mice

CpG Oligodeoxynucleotides Can Reverse Th2-associated Allergic Airway Responses and Alter the B7.1/B7.2 Expression in a Murine Model of Asthma.

Effects of Ozone Repeated Short Exposures on the Airway/lung Inflammation, Airway Hyperresponsiveness and Mucus Production in a Mouse Model of Ovalbumin-Induced Asthma.

Synthetic Oligodeoxynucleotide Containing CpG Motifs Enhancing the Production of Th1 Cytokines Induced by Dermatophagoides Farinae Allergens in Vitro

Influence of polyamine-chol cationic liposome-mediated CpGODN aerosol on the eosinophiles in the lung tissue of mouse with asthma

Enhanced Airway Inflammation and Decreased Subepithelial Fibrosis in Interleukin 6‐deficient Mice Following Chronic Exposure to Aerosolized Antigen

Oligodeoxynucleotides containing CpG motifs (CpG‐ODN) restores immune regulatory functions of airway macrophages of patients with asthma

Treatment of allergic rhinitis with CpG oligodeoxynucleotides alleviates the lower airway outcomes of combined allergic rhinitis and asthma syndrome via a mechanism that possibly involves in TSLP

The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma

Low Doses Of Exogenous Interferon-Gamma Attenuated Airway Inflammation Through Enhancing Fas/Fasl-Induced Cd4(+) T Cell Apoptosis In A Mouse Asthma Model

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

Diammonium Glycyrrhizinate Inhibits Airway Smooth Muscle Proliferation in a Murine Mod-El of Chronic Asthma

A CpG-Oligodeoxynucleotide Suppresses Th2/Th17 Inflammation by Inhibiting IL-33/ST2 Signaling in Mice from a Model of Adoptive Dendritic Cell Transfer of Smoke-Induced Asthma

PPARγ Agonist PGZ Attenuates OVA-Induced Airway Inflammation and Airway Remodeling Via RGS4 Signaling in Mouse Model

A20 Domain Protein Inhibits OVA-induced Airway Remodeling by Modulating the NF-κB/TGF-β1/CTGF Signaling Pathway in Asthmatic Mice

Effect of Lactobacillus rhamnosus GG immunopathologic changes in chronic mouse asthma model

Modulation of Allergic Airway Inflammation by Immunostimulatory DNA Sequences in Conjunction with an Allergen in a Murine Model of Asthma

Azithromycin Ameliorates OVA-induced Airway Remodeling in Balb/c Mice Via Suppression of Epithelial-to-mesenchymal Transition

Ganoderic Acid A Alleviates OVA-Induced Asthma in Mice